Case File
efta-02555415DOJ Data Set 11OtherEFTA02555415
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02555415
Pages
7
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S <
Sent:
Thursday, May 31, 2012 4:10 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Giuffrida, David
Subject:
To Do
Jeffrey
<1=>
We should buy t=is bond. Spending $1.7MM. Our base case has a yield of 9.72% with = 2.20yr duration. Our stress case
scenario sees the yield dropping to =.98% with similar duration.
=OA
Also our $3MM Chevro= note fixed today. Stock was flat and we got paid a 10.60%. So that =eaves us with $3.318MM in
cash. Will reprice some other ideas.<=o:p>
<=:p>
Paul
<1=>
US Onshore Clients — Blue Sky (U.S. State Secur=ties Law): Please confirm Blue Sky eligibility before soliciting to a US
O=shore client by entering the CUSIP into the web tool located at: <=
href="http://pscppvl.amer.jpmchase. net:8080/BlueSkyPage. html">h=tp://pscppvtamer.jpmchase. net:8080/BI ueSkyPa
ge.html =and review to see if your client's state of residence is listed. 1= you receive 'NO SECURITY FOUND', 'NO STATES
FOUND'= or the security DOES NOT HAVE A CUSIP or is not USD-denominated, th=n please contact your SM or local
compliance officer and provide the reque=ted security and client information. Please note that a suitability revi=w and
other pre-trade procedures must still be followed.
-
&nb=p; HPI Updated LTV = 64%
=OD 83% of=the borrowers have not missed a payment in the past 2 years
- &nbs=;
74% of the borrowers have not missed a payment si=ce inception 87 months ago
=OD 87 mon=hs seasoned
=OD
EFTA_R1_01713432
EFTA02555415
</=pan>726 FICO</=pan>
=0D $421 a=erage balance
- =
Time to recoup investment cost:<=b>
o =b>Stress case: 56 months
o Base case: 52 months
o Recovery case: 43 months
cable class="MsoNormalTable" border="0" cellspacing="0" cellpadding=3D"0" width="1201"
style="width:900.8pt;margin-left:-.75pt;border-=ollapse:collapse">
<=d width="453" nowrap="" colspan="2" valign="bottom" style="width=339.5pt;padding:0in 5.4pt 0in
5.4ptheight:16.5pt">
CMSI 2005-1 B2 Offered @ 83-00
=OD
=/td>
=0ABOND DESCRIPTION
=OD
Prepay Rate
28 for 20 24 for 12 20 for 618 CPR
30 ramp 24 34 30 CPR</=:p>
=OD Cusip:</=:p>
172973P94
=OA
1.5 for 48 1 CDR
=OA 1.5 for 36 1 CDR
<=td> =span style="font-size:8.0pt;font-family:"Arial","sans-s=rif";color:black">1 for 36 0.5 CDR
=OD
Original Face:
=OA
45 for 12 40
35
35</=pan>
<=d width="241" nowrap="" valign="bottom" style="width:180.75pt;pa=ding:0in 5.4pt 0in 5.4ptheight:14.15pr>
2
EFTA_R1_01713433
EFTA02555416
2,111,340
Seasoned 5.417% Prime Sub=/span>
=OD
<=>Price @ 83-00
Base Case</=>
-/NR/CCC
Yield
=0A2.986
9.722
=OD
Current Coupon:
5.420%<=o:p>
Spread
<=d width="163" nowrap="" valign="bottom" style="width:122.55ptpa=ding:Oin 5.4pt Oin 5.4pt;height:13.4pt">
219
894<=p>
1303
Yield @ Base Case
Duration=/p>
=OA
2.12
2.20
=OD
<=pan style="font-size:8.0ptfont-family:"Arial","sans-se=if";color:black">2.04
=OD
WAL @ Base Case
3.54
=OA
=OAWAL
3.58
3
EFTA_R1_01713434
EFTA02555417
3.54</=>
=u112 to Dec46
Principa= Window
=p class="MsoNormal" align="center" style="text-align:center">Jull2 to Dec46
Jul12 to M=y38
Writedown %
Principal Writedown
27.98%
13.29%
0.00%
Current Credit Enhancement=
2.03%
</=d>
=span style="font-size:8.0pOont-family:"Arial","sans-s=re;color:black">Total Collat Loss
=OD 0.34%
=OA 0.19%
=OD
60+ Delinquencies
2.94 =OA
Total Liquidation
4=2E13%
2.09%
=/td>
60+ Delinquency Coverage
0.69x
=td width="49" nowrap="" valign="bottom" style="width:36.5pt;padd=ng:0in 5.4pt 0in 5.4pt;height:13.4pt">
HISTORICAL PERFORMANCE
4
EFTA_R1_01713435
EFTA02555418
<=p> =o:p>
=OA
=NDERLYING COLLATERAL DESCRIPTION
1 MOS
3 MOS
=OA Average Lo=n Balance ($,000s)
<=td>
31.91
Loan Count
343<=o:p>
=OA
CDR
=OD 0.00
0.00<=span>
=OD
<=pan style="font-size:8.0pt;font-family:"Arial","sans-serif";color:#1F497D">0.00
=OD
<=pan style="font-size:8.0pt;font-family:"Arial","sans-se=if";color:black">Mortgage Type
=td width="212" nowrap="" valign="bottom" style="width:158.75pt;p=dding:0in 5.4pt 0in 5.4pt;height:13.4pt">
NA
<=td> NA
NA
Wtd Avg Mortgage Coupon<=:p>
5.625%
</=d>
=0AWtd Avg FICO Sco=e
5
EFTA_R1_01713436
EFTA02555419
726
=OD
=td width="241" nowrap="" valign="bottom" style="width:180.75pt;p=dding:0in 5.4pt 0in 5.4pt;height:13.4pt">
58.08%
=OD
=OD
HPI A=j LTV
64.11%
=OD
=OD
Weigh=ed Avg Loan Age
88</=>
=OD
Owner=Occupied
96.58
<=td>
=td width="163" nowrap="" valign="bottom" style="width:122.55pt;p=dding:0in 5.4pt 0in
5.4pt;height:13.4pt">
To= 1 Geo Concentration
CA 31%=/span>
=OD
<=d width="177" nowrap="" valign="bottom" style="width:132.9pt;pad=ing:0in 5.4pt 0in
5.4pt;height:13.4pt">
=OD
Top 2 Geo Concentration
NY 18%<=:p>
=OD
Top 3 Geo Concentration
=OA
82.55%
=OD
</=body>
&n=sp;
=/td>
=/td>
=/tr>
6
EFTA_R1_01713437
EFTA02555420
IMPORTANT DISCLAIMER:
No.-agency RMBS is a complex fixed income product and is not suitable for all=investors. Please note that while desk
assumptions are driven by a=number of collateral and macro factors, the historical performanc= of a deal is not
indicative of its future performance. Additi=nally, this message is a product of sales and trading and is not a researc=
report. Other key risks to consider are outlined below:
=DAAll investme=ts are subject to possible loss of principal
-&n=sp;
Non-Agency bonds may have limite= liquidity and clients should be aware that the secondary market for
mortg=ge-backed securities has experienced periods of illiquidity and may =o so in the future. Illiquidity means that
there may not be any purchase=s for your class of certificates. Although any class of certificates may=experience
illiquidity, it is more likely that classes that are lower in t=e capital structure and non-investment grade related may
experience =reater illiquidity than more senior, investment-grade rated classes.
-
=nbsp; High Yield Non-Agency bonds are speculative non-investment grade b=nds that have higher risk of default
or other adverse credit events which =re appropriate for high risk investors only
=OD
=/span>
This e=ail is confidential and subject to important disclaimers and conditions in=luding on offers for the purchase or sale
of securities, accuracy and comp=eteness of information, viruses, confidentiality, legal privilege, and leg=l entity
disclaimers, available at http://www.jpmorgan.com/pages/discl=sures/email.
7
EFTA_R1_01713438
EFTA02555421
Technical Artifacts (10)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
2555415Phone
2555416Phone
2555417Phone
2555418Phone
2555419Phone
2555420Phone
2555421URL
http://pscppvl.amer.jpmchaseURL
http://www.jpmorgan.com/pages/discl=sures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.